Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smart oxygen device shorten hospital stays for pneumonia?

NCT ID NCT03527992

Disease control Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial tests whether an automated oxygen delivery system, called FreeO2, can help patients with pneumonia recover faster and leave the hospital sooner. The device automatically adjusts oxygen flow based on continuous monitoring of blood oxygen levels, aiming to keep patients in a target range. Researchers compare this to standard oxygen therapy in adults hospitalized with pneumonia and low oxygen levels. The main goal is to see if automated oxygen reduces the total length of hospital stay.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Automated oxygen delivery via the FreeO2 device, which adjusts oxygen flow based on continuous saturation monitoring
What this could lead to
If effective, this automated system could reduce hospital stays for pneumonia patients, freeing up beds and lowering healthcare costs.
What could go wrong
The trial is small and early, and results may not apply to all pneumonia patients. The device might not significantly shorten hospital stays or could have technical issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

59 people

The number who actually took part.

Started

Mar 2018

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult * Patient living at home or in an institution * Patient hospitalized for less than 48 hours * Pneumonia defined (according to the 2006 French-speaking infectious pneumology society (SPILF) criteria) by: * respiratory functional symptoms (cough, sputum, dyspnea, chest pain) and * Hyperthermia \>38,5°C or hypothermia \<36°C and * Radiological Signs of Pneumonia * Hypoxia : SpO2 \< 94% in ambient air and/or PaO2\< 60 mmHg in ambient air Exclusion Criteria: * Pneumonia acquired at the hospital. * Patient hospitalized in another department more than 48 hours before admission * Chronic respiratory failure * Active neoplasia * Patients undergoing oxygen therapy and / or long-term NIV * Associated cardiac decompensation (clinical signs and / or NTproBNP\> 1800ng / mL) (3 * Initial Need for high flow oxygen therapy or ventilatory support (NIV, VI) * Difficulties expected from home support.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Length of stay are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pneumonia Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Length of stay Pneumonia Pneumonia, ventilator-associated

Contacts and locations

Locations

  • CHU Larrey

    Toulouse, 31049, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.